Page 16 - Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Axsm Today - Breaking & Trending Today

Strs Ohio Sells 800 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Strs Ohio trimmed its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) by 14.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 4,600 shares of the company’s stock after selling 800 shares during the quarter. Strs Ohio’s holdings in Axsome Therapeutics were worth $173,000 at the end of the most recent […] ....

United States , Axsome Therapeutics Inc , Atticus Wealth Management , Key Financial Inc , Zacks Investment Research , Jefferies Financial Group , Advisor Group Holdings Inc , Kestra Advisory Services , Strs Ohio , Axsome Therapeutics , Get Rating , Wealth Management , Financial Inc , Group Holdings , Advisory Services , Investment Research , Financial Group , Therapeutics Profile , Visit Holdingschannel , Nasdaq Axsm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Buy" by Brokerages

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been assigned an average recommendation of “Buy” from the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and nine have issued a buy recommendation on the […] ....

United States , Steward Partners Investment Advisory , Axsome Therapeutics Inc , Atticus Wealth Management , Key Financial Inc , Zacks Investment Research , Tortoise Investment Management , Nisa Investment Advisors , Jefferies Financial Group , Axsome Therapeutics Company Profile Get Rating , Axsome Therapeutics , Get Rating , Marketbeat Ratings , Financial Group , Wealth Management , Financial Inc , Investment Management , Investment Advisors , Partners Investment Advisory , Therapeutics Company Profile , Nasdaq Axsm ,

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 14.9% After Analyst Upgrade

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) rose 14.9% during trading on Tuesday after Jefferies Financial Group raised their price target on the stock from $71.00 to $77.00. Jefferies Financial Group currently has a buy rating on the stock. Axsome Therapeutics traded as high as $40.79 and last traded at $40.33. Approximately 30,154 […] ....

United States , Steward Partners Investment Advisory , Axsome Therapeutics Inc , Atticus Wealth Management , Key Financial Inc , Zacks Investment Research , Tortoise Investment Management , Nisa Investment Advisors , Jefferies Financial Group , Axsome Therapeutics , Get Rating , Financial Group , Investment Research , Wealth Management , Financial Inc , Investment Management , Investment Advisors , Partners Investment Advisory , Nasdaq Axsm ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Consensus Recommendation of "Buy" from Brokerages

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been assigned an average recommendation of “Buy” from the ten analysts that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price objective […] ....

United States , Axsome Therapeutics Inc , Zacks Investment Research , Norges Bank , Blackrock Inc , Parametric Portfolio Associates , Wells Fargo Company , Axsome Therapeutics Company Profile Get Rating , Axsome Therapeutics , Get Rating , Marketbeat Ratings , Investment Research , State Teachers Retirement System , Portfolio Associates , Therapeutics Company Profile , Nasdaq Axsm ,

Axsome Therapeutics (NASDAQ:AXSM) Shares Gap Up to $33.61

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating)’s share price gapped up prior to trading on Monday . The stock had previously closed at $33.61, but opened at $34.50. Axsome Therapeutics shares last traded at $34.50, with a volume of 1 shares traded. A number of brokerages recently issued reports on AXSM. SVB Leerink lowered their […] ....

New York , United States , Axsome Therapeutics Inc , Cubist Systematic Strategies , Zacks Investment Research , Baldwin Brothers , Royal Bank , Belvedere Trading , Axsome Therapeutics , Get Rating , Investment Research , Systematic Strategies , Sigma Investments , Herriot Tabuteau , Nasdaq Axsm ,